
BiologicalActivity
p38MAPKinhibitor.InhibitsLPS-inducedtranscriptionofarangeofchemokinesandcytokinesinchronicobstructivepulmonarydisease(COPD)monocytederivedmacrophages(MDMs).AlsoinhibitsLPS-inducedproteinexpressionofIL-6,IL-10,TNFαandγ-inducIBLeprotein10inCOPDMDMs.EffectsonsuppressionofLPS-inducedgeneandproteinexpressionareenhancedincombinationwithdexamethasone(Cat.No.1126).
LicensingInformation
SoldforresearchpurposesunderagreementfromGlaxoSmithKline
TechnicalData
M.Wt | 492.46 |
Formula | C24H19F3N8O |
Storage | DesiccateatRT |
Purity | ≥98%(HPLC) |
CASNumber | 911110-38-8 |
PubChemID | 11853799 |
InChIKey | ZQFBVJBAWLZLOM-UHFFFAOYSA-N |
Smiles | N=C(NC#N)NCCNC1=NC(C4=C(C)C=C(F)C=C4)=C(C=CC(N2C3=C(F)C=CC=C3F)=O)C2=N1 |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
SolubilityData
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 49.25 | 100 |
PreparingStockSolutions
Thefollowingdataisbasedontheproductmolecularweight492.46.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 2.03mL | 10.15mL | 20.31mL |
5mM | 0.41mL | 2.03mL | 4.06mL |
10mM | 0.2mL | 1.02mL | 2.03mL |
50mM | 0.04mL | 0.2mL | 0.41mL |